Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer

Journal of the National Cancer Institute

Volumn 104, Issue 12, 2012, Pages 931-940

  Chubak, Jessica ^a,b   Yu, Onchee ^a   Pocobelli, Gaia ^a,b   Lamerato, Lois ^c   Webster, Joe ^a   Prout, Marianne N ^d   Ulcickas Yood, Marianne ^d   Barlow, William E ^a,e   Buist, Diana S M ^a,b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INVASION; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; DATA ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; WASHINGTON;

EID: 84864118214     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs233     Document Type: Article

References (24)

1. National Cancer Institute. Overview of the SEER Program; 2011. http :://seer. cancer. gov/about/overview. html. Accessed April 4, 2012.
2. Chen SL, Martinez SR. The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence. Am J Surg. 2008; 196 (4): 495-499.
3. Hershman D, Neugut AI, Jacobson JS, et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007; 99 (3): 196-205.
4. Thompson D, Taylor DC, Montoya EL, Winer EP, Jones SE, Weinstein MC. Cost-effectiveness of switching to exemestane after 2 to 3 years of therapy with tamoxifen in postmenopausal women with early-stage breast cancer. Value Health. 2007; 10 (5): 367-376. (Pubitemid 47485660)
5. Stokes ME, Thompson D, Montoya EL, Weinstein MC, Winer EP, Earle CC. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-Medicare data. Value Health. 2008; 11 (2): 213-220. (Pubitemid 351473603)
6. Srokowski TP, Fang S, Duan Z, et al. Completion of adjuvant radiation therapy among women with breast cancer. Cancer. 2008; 113 (1): 22-29. (Pubitemid 351976382)
7. Smith BD, Haffty BG, Buchholz TA, et al. Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J. Natl Cancer Inst. 2006; 98 (18): 1302-1310. (Pubitemid 44538160)
8. Earle CC, Nattinger AB, Potosky AL, et al. Identifying cancer relapse using SEER-Medicare data. Med Care. 2002; 40 (8 Suppl): IV-75-IV-81.
9. Eichler AF, Lamont EB. Utility of administrative claims data for the study of brain metastases: a validation study. J Neurooncol. 2009; 95 (3): 427-431.
10. McClish D, Penberthy L, Pugh A. Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry. J Clin Epidemiol. 2003; 56 (8): 760-767. (Pubitemid 37040812)
11. Lamont EB, Herndon JE II, Weeks JC, et al. Measuring disease-free survival and cancer relapse using medicare claims from CALGB Breast Cancer Trial Participants (Companion to 9344). J Natl Cancer Inst. 2006; 98 (18): 1335-1338. (Pubitemid 44530729)
12. Geiger AM, Thwin SS, Lash TL, et al. Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer. 2007; 109 (5): 966-974. (Pubitemid 46333538)
13. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology. Cancer. 2002; 95 (10): 2059-2067.
14. Janschek E, Kandioler-Eckersberger D, Ludwig C, et al. Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat. 2001; 67 (1): 1-8. (Pubitemid 32703382)
15. Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000; 48 (5): 1281-1289.
16. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 365 (9472): 1687-1717.
17. Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized defi nitions for effi cacy end points in adjuvant breast cancer trials: the STEEP System. J Clin Oncol. 2007; 25 (15): 2127-2132. (Pubitemid 46972801)
18. Aydiner A, Tas F. Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer. Trials. 2008; 9 (1): 47.
19. Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish Nationwide Prospective Cohort Study. J Natl Cancer Inst. 2011; 103 (19): 1461-1468.
20. Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis . Breast Cancer Res Treat. 2008; 112 (1): 123-132.
21. Group Health. Group Health Overview; 2011. http :://www. ghc. org/about-gh/co-op-overview/index. jhtml. Accessed April 4, 2012.
22. Breiman L, Friedman J, Olshen R, Stone C. Classifi cation and Regression Trees. Belmont, CA : Wadsworth; 1984.
23. Benchimol EI, Manuel DG, To T, Griffi ths AM, Rabeneck L, Guttmann A. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol. 2011; 64 (8): 821-829.
24. Chubak J, Pocobelli G, Weiss NS. Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol. 2012; 65 (3): 343.e2-349.e2.